457 related articles for article (PubMed ID: 19555589)
1. NCCN Task Force Report: Bone Health in Cancer Care.
Gralow JR; Biermann JS; Farooki A; Fornier MN; Gagel RF; Kumar RN; Shapiro CL; Shields A; Smith MR; Srinivas S; Van Poznak CH
J Natl Compr Canc Netw; 2009 Jun; 7 Suppl 3(Suppl 3):S1-32; quiz S33-5. PubMed ID: 19555589
[TBL] [Abstract][Full Text] [Related]
2. New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.
Rosen LS
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):26-32. PubMed ID: 15202585
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.
J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137
[No Abstract] [Full Text] [Related]
4. [Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer].
Kudlacek S; Puntus T
Wien Med Wochenschr; 2012 Sep; 162(17-18):380-5. PubMed ID: 22875632
[TBL] [Abstract][Full Text] [Related]
5. Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer.
Saylor PJ
Asian J Androl; 2014; 16(3):341-7. PubMed ID: 24435057
[TBL] [Abstract][Full Text] [Related]
6. Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer.
McKay RR; Taplin ME; Choueiri TK
Hematol Oncol Clin North Am; 2013 Dec; 27(6):1261-83, ix. PubMed ID: 24188262
[TBL] [Abstract][Full Text] [Related]
7. Management of bone loss due to endocrine therapy during cancer treatment.
Khan MI
Osteoporos Int; 2023 Apr; 34(4):671-680. PubMed ID: 36656338
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of bone loss in patients with nonmetastatic breast or prostate cancer who receive hormonal ablation therapy.
Limburg C; Maxwell C; Mautner B
Clin J Oncol Nurs; 2014 Apr; 18(2):223-30. PubMed ID: 24675258
[TBL] [Abstract][Full Text] [Related]
9. Preservation of bone health in prostate cancer.
Lattouf JB; Saad F
Curr Opin Support Palliat Care; 2007 Oct; 1(3):192-7. PubMed ID: 18685362
[TBL] [Abstract][Full Text] [Related]
10. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
Candelaria-Quintana D; Dayao ZR; Royce ME
Breast Cancer Res Treat; 2012 Apr; 132(2):355-63. PubMed ID: 21987034
[TBL] [Abstract][Full Text] [Related]
11. Annual zoledronic acid: is less more?
Higano CS
J Clin Oncol; 2007 Mar; 25(9):1026. PubMed ID: 17369565
[No Abstract] [Full Text] [Related]
12. The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy.
Smith MR
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):21-5. PubMed ID: 15202584
[TBL] [Abstract][Full Text] [Related]
13. [Bone targeting agents: bisphosphonates].
Debiais F
Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
[TBL] [Abstract][Full Text] [Related]
14. Metastasis and bone loss: advancing treatment and prevention.
Coleman RE; Lipton A; Roodman GD; Guise TA; Boyce BF; Brufsky AM; Clézardin P; Croucher PI; Gralow JR; Hadji P; Holen I; Mundy GR; Smith MR; Suva LJ
Cancer Treat Rev; 2010 Dec; 36(8):615-20. PubMed ID: 20478658
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy.
Saad F; Sternberg CN
Nat Clin Pract Urol; 2007 Feb; 4 Suppl 1():S3-13. PubMed ID: 17264863
[TBL] [Abstract][Full Text] [Related]
16. How can we improve the treatment of bone metastases further?
Coleman RE
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S7-13. PubMed ID: 9801853
[TBL] [Abstract][Full Text] [Related]
17. Bone health after diagnosis of breast cancer.
Ruzycki SM; Nixon NA
CMAJ; 2018 Dec; 190(49):E1452. PubMed ID: 30530612
[No Abstract] [Full Text] [Related]
18. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
19. NCCN Task Force Report: Bone Health In Cancer Care.
Gralow JR; Biermann JS; Farooki A; Fornier MN; Gagel RF; Kumar R; Litsas G; McKay R; Podoloff DA; Srinivas S; Van Poznak CH
J Natl Compr Canc Netw; 2013 Aug; 11 Suppl 3():S1-50; quiz S51. PubMed ID: 23997241
[TBL] [Abstract][Full Text] [Related]
20. [Bone and Men's Health. Bisphosphonate therapy for prostate cancer].
Suzuki H; Kamiya N; Yano M; Endo T; Takano M; Kawamura K; Imamoto T; Ichikawa T
Clin Calcium; 2010 Feb; 20(2):258-66. PubMed ID: 20118519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
